However, the hyper-production of IL-23 by innate myeloid cells in IBD patients might be associated with dysregulated BATF2 expression possibly related to disrupted epigenetic modification of the BATF2 gene or secondary effects of IBD-related molecules such as IFNAR. Here, IL23A is linked to inflammatory bowel disease.